Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1868 USD | +0.98% |
|
-1.79% | -18.36% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
| Market Cap | 307M 269M 248M 231M 436M 29.01B 444M 2.97B 1.15B 14.32B 1.15B 1.13B 49.87B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 403M 353M 326M 304M 572M 38.09B 582M 3.9B 1.52B 18.8B 1.51B 1.48B 65.49B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.1x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.98% | ||
| 1 week | -1.79% | ||
| 1 month | -17.53% | ||
| 3 months | -9.54% | ||
| 6 months | -18.36% | ||
| Current year | -18.36% |
| 1 week | 0.18 |  | 0.2 |
| 1 month | 0.18 | | 0.24 |
| Current year | 0.18 | | 0.34 |
| 1 year | 0.18 | | 0.37 |
| 3 years | 0.17 | | 1.09 |
| 5 years | 0.17 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 31/05/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 07/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 31/12/1997 |
Linda Powers
CHM | Chairman | 71 | 16/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 31/03/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 08/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 07/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | -1.79% | -22.13% | -67.11% | 307M | |
| +3.31% | -0.20% | +72.71% | +128.31% | 55.78B | |
| -1.32% | +17.12% | +79.02% | +99.82% | 55.66B | |
| -1.28% | +2.68% | -12.60% | -13.79% | 23.84B | |
| +1.79% | +4.38% | +5.94% | +405.31% | 22.7B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.5B | |
| +4.45% | +5.06% | +36.50% | -30.43% | 16.12B | |
| +0.24% | +5.98% | +23.45% | +184.72% | 13.64B | |
| +0.14% | +9.60% | +33.31% | - | 12.95B | |
| +1.83% | +4.58% | +77.42% | +132.45% | 12.16B | |
| Average | +0.82% | +5.31% | +32.85% | +92.38% | 23.17B | |
| Weighted average by Cap. | +0.80% | +5.20% | +48.38% | +114.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.08M 31.46M 29.34M 55.29M 3.68B 56.28M 377M 146M 1.82B 146M 143M 6.33B |
| Net income | - | - |
| Net Debt | 96.08M 84.1M 77.63M 72.41M 136M 9.08B 139M 931M 362M 4.48B 361M 353M 15.62B | 125M 109M 101M 94.17M 177M 11.81B 181M 1.21B 470M 5.83B 469M 459M 20.31B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$0.1868 | +0.98% | 1,651,673 |
| 29/06/26 | US$0.1850 | -4.59% | 7,103,920 |
| 26/06/26 | US$0.1939 | +4.27% | 5,291,119 |
| 25/06/26 | US$0.1860 | -1.66% | 3,237,943 |
| 24/06/26 | US$0.1891 | -0.58% | 1,796,624 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1868USD
Average target price
1.000USD
Spread / Average Target
+435.30%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
